Research may provide gluten exposure safety net

02/27/2013 | U.S. News & World Report

Ongoing studies may yield treatments that make gluten less toxic to people with celiac disease or those who are gluten sensitive, says dietitian Tamara Duker Freuman. Researchers are testing larazotide acetate as a way to block a reaction if small amounts of gluten are unintentionally consumed, along with enzyme therapies that could disarm gluten before it harms the digestive system.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX